Episode
Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
- Podcast
- Breast Cancer Update
- Published
- Jan 27, 2026
- Duration seconds
- 7267
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/endocrine-based-therapy-for-hr-positive-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/breast-cancer-update-757579/endocrine-based-therapy-for-hr-positive-breast-cancer-proceedings-from-a-san-antonio-2025-symposium-series.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Angela DeMichele from the Abramson Cancer Center in Philadelphia, Pennsylvania, Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Seth Wander from Massachusetts General Hospital in Boston discuss real-world cases and recent clinical data surrounding the management of HR-positive breast cancer. CME information and select publications here .